Sonoma Pharmaceuticals, Inc. SEC filings SNOA
Sonoma Pharmaceuticals, Inc. has 977 filings in SEC EDGAR's recent list, going back to Jan 15, 2002. Its latest annual report, Form 10-K, was filed on Jun 16, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-A12B/A | Amendment to form 8-a12b | Oct 6, 2026 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 17, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 19, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| DEF 14A | Proxy statement | Jul 28, 2026 | Sep 16, 2026 |
| DEFA14A | Additional proxy material | Jul 23, 2026 | — |
| S-8 | Employee stock plan registration | Jul 9, 2026 | — |
| DEFA14A | Additional proxy material | Jun 24, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 18, 2026 | Jun 18, 2026 |
| 424B5 | Prospectus supplement | Jun 18, 2026 | — |
| 10-K | Annual report | Jun 16, 2026 | Mar 31, 2026 |
| DEF 14A | Proxy statement | May 5, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 30, 2026 | Apr 24, 2026 |
| 424B4 | Prospectus | Apr 27, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 27, 2026 | Apr 24, 2026 |
| EFFECT | Filing | Apr 23, 2026 | — |
| S-1/A | Amended registration statement | Apr 23, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| S-1 | Registration statement | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2026 | — |
| DRS | Filing | Apr 9, 2026 | — |
| 8-K |
Current report
Material agreement
|
Apr 9, 2026 | Apr 8, 2026 |
| 10-Q | Quarterly report | Feb 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2026 | Jan 2, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2025 | Oct 18, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Other events
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 26, 2025 | Sep 26, 2025 |
| 424B5 | Prospectus supplement | Sep 26, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 29, 2025 | Aug 27, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| DEF 14A | Proxy statement | Jul 11, 2025 | Aug 27, 2025 |
| S-8 | Employee stock plan registration | Jun 17, 2025 | — |
| 10-K | Annual report | Jun 17, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Other events
|
Apr 7, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 25, 2025 | Mar 21, 2025 |
| 10-Q | Quarterly report | Feb 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 30, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2025 | Jan 2, 2025 |
| S-8 | Employee stock plan registration | Dec 20, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Nov 21, 2024 | Nov 21, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 22, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Aug 28, 2024 | Aug 23, 2024 |
| 8-K |
Current report
Other events
|
Aug 23, 2024 | Aug 22, 2024 |
| 424B5 | Prospectus supplement | Aug 23, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 21, 2024 | Aug 19, 2024 |
| DEFA14A | Additional proxy material | Aug 15, 2024 | — |
| DEFA14A | Additional proxy material | Aug 15, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| DEFA14A | Additional proxy material | Jul 24, 2024 | — |
| DEF 14A | Proxy statement | Jul 1, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| PRE 14A | Preliminary proxy statement | Jun 21, 2024 | Aug 14, 2024 |
| S-8 | Employee stock plan registration | Jun 17, 2024 | — |
| 10-K | Annual report | Jun 17, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 9, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2024 | Apr 2, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 22, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 8, 2024 | Mar 8, 2024 |
| 424B3 | Prospectus | Mar 8, 2024 | — |
| 10-Q | Quarterly report | Feb 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 9, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2023 | Dec 29, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 18, 2023 | Dec 15, 2023 |
| 424B3 | Prospectus | Dec 15, 2023 | — |
| 424B5 | Prospectus supplement | Nov 22, 2023 | — |
| EFFECT | Filing | Nov 20, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Nov 7, 2023 | — |
| S-3 | Shelf registration | Nov 3, 2023 | — |
| 424B4 | Prospectus | Oct 30, 2023 | — |
| EFFECT | Filing | Oct 26, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| CORRESP | Letter to the SEC | Oct 13, 2023 | — |
| S-1/A | Amended registration statement | Oct 13, 2023 | — |
| 8-K/A |
Amended current report
Other events
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Sep 28, 2023 | Sep 22, 2023 |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| S-1 | Registration statement | Sep 19, 2023 | — |
| DEFA14A | Additional proxy material | Sep 15, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| DEF 14A | Proxy statement | Jul 27, 2023 | Sep 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2023 | Jul 11, 2023 |
| 10-K | Annual report | Jun 21, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2023 | Apr 7, 2023 |
| 424B5 | Prospectus supplement | Feb 24, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 24, 2023 | Feb 24, 2023 |
| 10-Q | Quarterly report | Feb 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 31, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2022 | Dec 29, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2022 | Dec 23, 2022 |
| 424B3 | Prospectus | Dec 23, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2022 | Sep 15, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Jul 22, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 22, 2022 |
| 10-K | Annual report | Jul 13, 2022 | Mar 31, 2022 |
| NT 10-K | Form 12b-25 | Jun 29, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Feb 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 20, 2022 | Jan 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2022 | Jan 14, 2022 |
| S-8 | Employee stock plan registration | Jan 13, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2022 | Jan 6, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 9, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 21, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Other events
|
Sep 3, 2021 | Sep 3, 2021 |
| 424B3 | Prospectus | Sep 3, 2021 | — |
| DEFA14A | Additional proxy material | Aug 30, 2021 | — |
| DEFA14A | Additional proxy material | Aug 23, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| DEFA14A | Additional proxy material | Aug 16, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2021 | Jul 27, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 30, 2021 | Jul 30, 2021 |
| 424B3 | Prospectus | Jul 30, 2021 | — |
| DEF 14A | Proxy statement | Jul 29, 2021 | Sep 15, 2021 |
| 8-K |
Current report
Auditor change
|
Jul 20, 2021 | Jul 15, 2021 |
| 10-K | Annual report | Jul 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Auditor change
|
Jul 9, 2021 | Jul 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2021 | Jul 1, 2021 |
| NT 10-K | Notification of late filing | Jun 29, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 31, 2021 | Mar 26, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2021 | Mar 4, 2021 |
| 10-Q | Quarterly report | Feb 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2021 | Jan 4, 2021 |
| 424B5 | Prospectus supplement | Dec 23, 2020 | — |
| EFFECT | Filing | Dec 22, 2020 | — |
| CORRESP | Letter to the SEC | Dec 18, 2020 | — |
| 8-K |
Current report
Material agreement
|
Dec 17, 2020 | Dec 14, 2020 |
| CORRESP | Letter to the SEC | Dec 15, 2020 | — |
| S-3/A | Form s-3 amendment 1 | Dec 15, 2020 | — |
| 8-K |
Current report
Material agreement
|
Dec 10, 2020 | Dec 4, 2020 |
| UPLOAD | Letter from the SEC | Dec 7, 2020 | — |
| S-3 | Shelf registration | Nov 24, 2020 | — |
| 10-Q | Quarterly report | Nov 20, 2020 | Sep 30, 2020 |
| 10-Q/A | Amended quarterly report | Nov 17, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Restatement
|
Nov 17, 2020 | Nov 12, 2020 |
| NT 10-Q | Filing | Nov 16, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Sep 18, 2020 | Sep 18, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2020 | Sep 8, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 6, 2020 | Jul 31, 2020 |
| DEF 14A | Proxy statement | Jul 29, 2020 | Sep 18, 2020 |
| 10-K | Annual report | Jul 10, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jun 29, 2020 | Jun 24, 2020 |
| NT 10-K | Form 12b-25 (nt 10-k) | Jun 29, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2020 | May 29, 2020 |
| 8-K |
Current report
Material agreement
|
May 26, 2020 | May 19, 2020 |
| 8-K |
Current report
Material agreement
|
May 4, 2020 | Apr 29, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 20, 2020 | Apr 14, 2020 |
| 8-K |
Current report
Material agreement
|
Feb 27, 2020 | Feb 21, 2020 |
| 10-Q | Quarterly report | Feb 14, 2020 | Dec 31, 2019 |
| 25-NSE | Delisting notice | Jan 22, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Dec 31, 2019 | Dec 26, 2019 |
| S-8 | Employee stock plan registration | Dec 26, 2019 | — |
| 8-K |
Current report
Material agreement
|
Nov 29, 2019 | Nov 26, 2019 |
| 424B3 | Prospectus | Nov 27, 2019 | — |
| 424B3 | Prospectus | Nov 26, 2019 | — |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Nov 6, 2019 | Nov 5, 2019 |
| DEFA14A | Additional proxy material | Oct 18, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2019 | Oct 8, 2019 |
| DEFA14A | Additional proxy material | Oct 9, 2019 | — |
| DEFA14A | Additional proxy material | Oct 3, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2019 | Sep 25, 2019 |
| DEFA14A | Additional proxy material | Sep 18, 2019 | — |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| DEF 14A | Proxy statement | Jul 29, 2019 | Sep 17, 2019 |
| 10-K | Annual report | Jul 1, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 19, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2019 | Jun 11, 2019 |
| DEFA14A | Additional proxy material | May 31, 2019 | — |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2019 | May 30, 2019 |
| 8-K |
Current report
Material agreement
|
May 22, 2019 | May 20, 2019 |
| DEF 14A | Proxy statement | Apr 22, 2019 | May 30, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2019 | May 14, 2019 |
| 10-Q | Quarterly report | Feb 14, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Listing notice
|
Jan 8, 2019 | Jan 4, 2019 |
| S-8 | Employee stock plan registration | Dec 19, 2018 | — |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2018 | Dec 11, 2018 |
| 8-K |
Current report
Other events
|
Nov 28, 2018 | Nov 27, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SNOA (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1367083
- Former names
- Oculus Innovative Sciences, Inc. (until Dec 2, 2016)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.